FIFTH ANNUAL REPORT • GENERICS Generic companies across the globe are in consolidation mode via M&A activity with fellow industry players as well as big pharma. By Andrew Humphreys
To the point Bugged about science By Christiane Truelove
The forgotten sales force As contracted sales account for an ever higher percentage of brand dollars, companies are looking for ways to make their managed-care sales forces more effective through improved resources and integration. By Steven Niles
Ad-ventures in marketing II Med Ad News has chosen four Pharmaceutical Marketing Ventures to Watch from a variety of young, creative venture companies that could change the way pharmaceutical products are marketed and sold. By Joshua Slatko
More than compassion Expanded-access programs have the potential to save lives while adding value to marketers’ investigational drugs before market approval. By Gina-Louise Monari
Sales & Marketing Pharmaceutical sales representatives need to develop a better understanding of the medical practices they serve. By Joshua Slatko
Pharma Business After turning down an inferior offer from Bristol-Myers Squibb, ImClone Systems has accepted a $6.5 billion bid from Eli Lilly. By Steven Niles
People on the Move Christopher Perley has been named VP and general manager of Bristol-Myers Squibb’s Devens biologics manufacturing facility. By Gina-Louise Monari
Adwise Vox Medica is asking clients to forget the business silos of the healthcare communications company’s old structure by unveiling a new model designed to deliver inventive healthcare solutions in a more relevant and refreshing way. By Gina-Louise Monari
e-marketing Pfizer has launched a new interactive online educational resource, and Eli Lilly’s CEO has outlined plans for the company’s online registry of physician payments. By Joshua Slatko
FDA Files FDA has accused the marketers of Adderall XR, Concerta, Focalin XR, Methylin, and Strattera of misleading consumers with their product claims. By Steven Niles
Drug Approvals FDA’s most-recent approval of Eli Lilly’s Alimta expands the use of the medication for patients with nonsquamous histology. By Gina-Louise Monari
Account manager ROI Med Ad News spoke with Chris Blenk, senior principle, IMS Consulting, about how companies can measure the return on investment they receive from their account management teams.
Backing the terminally ill Patients rights groups continue to lobby on behalf of terminally ill patients for legal rights to expanded access programs.
Expanded-access programs This online resource presents 79 investigative drugs made available through expanded-access programs.
Reach an engaged audience with your brand's message
Download the Med Ad News, R&D Directions, and PharmaLive.com media kit
New
Special Report from PharmaLive.com!
Top 15 Therapeutic Groups More Information
Today's Health
Today's Health, America's #1 Educational Health Care Television Series, provides an exciting look at the latest innovations in medicine and Healthcare.
Subscribe Now and Save!
Get access to premium content, free PDF reports, and more!
Guide to Contract Research Services
The Guide to Contract Research Services contains in-depth profiles of quality providers of a variety of contract research services. Click here to view advertiser profiles.
The Trend Report
Guideline Inc. has teamed up with Med Ad News to provide the special supplement, 2008 Patient Adherence Update: New Approaches for Success
